PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 25.30
+0.05 (0.20%)
At close: Nov 28, 2025
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 834.68 million as of November 28, 2025. Its market cap has decreased by -17.97% in one year.
Market Cap
834.68M
Enterprise Value
867.02M
Revenue
344.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.30
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 834.68M, a decrease of -67.78%. That is a compound annual growth rate of -21.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 834.68M | -10.89% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | 2.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 264.79B |
| Novartis AG | 200.78B |
| Lonza Group AG | 38.40B |
| Galderma Group AG | 37.65B |
| Alcon | 31.41B |
| Sandoz Group AG | 24.20B |
| Straumann Holding AG | 14.91B |
| Sonova Holding AG | 11.99B |